Neudle.com: rtPA

Differential
(Click to cross reference)

abciximab

acalculia

advances in neurology

adverse drug reaction

aggrenox

air transport

Alberta Stroke Program Early CT score

alcohol, neurologic complications with

Alzheimer's disease, early onset

Alzheimer's disease, treatment of

Alzheimer's disease, visual variant

ambulance

amyloid angiopathy, cerebral

amyloid beta protein

amyloid-related imaging abnormalities

aneurysm, intracranial

aneurysm, multiple intracranial

angioedema, tongue

angiography, cerebral

angiography, neurologic complications with

angiography, posterior fossa

angioneurotic edema

angiotensin-converting enzyme, inhibitors

anosognosia

anterior cerebral artery

anterior cerebral artery territory infarction

anterior cerebral artery, emboli to

anterior cerebral artery, occlusion of

anterior choroidal artery

anterior spinal artery

anterior spinal artery infarction

anterior temporal branch of posterior cerebral artery

anticoagulant, complications of

anticoagulant, reversal of

anticoagulant, treatment

anticoagulant, treatment in CVD

anticoagulant, treatment, combined

antiphospholipid antibodies

arterial dissection, aorta

arterial dissection, basilar

arterial dissection, carotid

arterial dissection, recurrent

arterial dissection, vertebral

arterial perforation

arteriopathy

arteriovenous malformation

arteriovenous malformation, cerebral

arteriovenous malformation, cerebral, ruptured

arteriovenous malformation, pulmonary

bacterial endocarditis, neurologic manifestations of

Balint's syndrome

baroreceptors

basal ganglia, hemorrhage

basilar artery

basilar artery occlusion

basilar artery plaque

basilar artery stenosis

biologic markers

biotinidase deficiency

blood pressure after stroke

blood pressure, asymmetric

blood transfusion

body temperature

brain purpura

brainstem, infarction of

cancer, cerebrovascular accident complicating patients with

carcinoma

cardiac catheterization

cardiac catheterization, neurologic complications

carotid artery atherosclerosis

carotid artery disease

carotid artery disease, medical management

carotid artery occlusion, intracranial

carotid artery occlusion, neck

carotid artery occlusion, recurrent

carotid artery stenosis

carotid artery stenosis, preocclusive

carotid artery stenosis, recurrent

carotid artery stenosis, tandem

carotid artery, intraluminal clot

carpal tunnel syndrome

CAT scan

CAT scan, abdomen

CAT scan, abnormal

CAT scan, angiography

CAT scan, angiography, false negative

CAT scan, angiography, false positive

CAT scan, angiography, source images

CAT scan, attenuation coefficient

CAT scan, cerebrovascular disease

CAT scan, chest

CAT scan, contrast enhanced

CAT scan, contrast extravasation

CAT scan, dense artery sign

CAT scan, dense artery sign, disappearing

CAT scan, disappearing lesion on

CAT scan, early changes in CVA

CAT scan, false negative

CAT scan, false positive

CAT scan, fluid-blood level

CAT scan, gyral swelling

CAT scan, helical

CAT scan, hypoattenuation

CAT scan, mass effect on

CAT scan, mismatch between cerebral blood volume/flow

CAT scan, mismatch between perfusion/diffusion

CAT scan, net water uptake

CAT scan, pelvis

CAT scan, perfusion

CAT scan, stereotactic localization

CAT scan, venography

CAT scan, xenon-enhanced

cavernous hemangioma

central artery of Percheron

central retinal artery occlusion

central venous catheter

cerebellar hemorrhage

cerebellar infarction

cerebral arteries

cerebral blood flow

cerebral edema

cerebral edema, cytotoxic

cerebral embolism

cerebral embolism, cardiac origin

cerebral embolism, mechanical extraction

cerebral infarction

cerebral infarction, hemorrhagic

cerebral infarction, small, deep

cerebral ischemia

cerebral vasculature

cerebral veins

cerebral venous infarction

cerebral venous thrombosis

cerebral venous thrombosis, deep

cerebral venous thrombosis, etiology

cerebral venous thrombosis, recurrent

cerebrovascular accident

cerebrovascular accident, acute management of

cerebrovascular accident, age of lesion

cerebrovascular accident, anticoagulant treatment

cerebrovascular accident, arterial occlusion, location

cerebrovascular accident, awakening with

cerebrovascular accident, bilateral

cerebrovascular accident, cardiac disease causing

cerebrovascular accident, circadian rhythm

cerebrovascular accident, classification

cerebrovascular accident, clinical diagnosis

cerebrovascular accident, complications with

cerebrovascular accident, cost of

cerebrovascular accident, delay in presentation

cerebrovascular accident, delay in treatment

cerebrovascular accident, etiology

cerebrovascular accident, infancy and childhood

cerebrovascular accident, in-hospital

cerebrovascular accident, location of

cerebrovascular accident, migraine causing

cerebrovascular accident, mimics

cerebrovascular accident, minor

cerebrovascular accident, misdiagnosis

cerebrovascular accident, multiple

cerebrovascular accident, nontreatment of

cerebrovascular accident, pathophysiology

cerebrovascular accident, postoperative

cerebrovascular accident, prehospital screening

cerebrovascular accident, prehospital treatment

cerebrovascular accident, prevention of

cerebrovascular accident, prognosis in

cerebrovascular accident, racial differences

cerebrovascular accident, recurrent

cerebrovascular accident, rehabilitation of

cerebrovascular accident, seizure with

cerebrovascular accident, severity

cerebrovascular accident, silent

cerebrovascular accident, spontaneous improvement after

cerebrovascular accident, stuttering

cerebrovascular accident, surgical treatment of

cerebrovascular accident, thrombolytic agents in treatment

cerebrovascular accident, thromobolytic agents in treatment, early dramatic recovery

cerebrovascular accident, time of onset

cerebrovascular accident, time of presentation

cerebrovascular accident, time to treatment

cerebrovascular accident, unknown time of onset

cerebrovascular accident, vascular territory involved

cerebrovascular accident, volume

cerebrovascular accident, women

cerebrovascular accident, work up for

cerebrovascular accident, young adult

cerebrovascular disease

cerebrovascular disease, noninvasive evaluation of

cerebrovascular disease, risk factors in

cerebrovascular disease, surgical treatment of

cerebrovascular disease, treatment of

Clinical Pathologic Conference(C.P.C.)

collateral circulation

computers, medicine and

computers, neurologic diagnosis and

contrast agents, neurotoxicity of

controversies in neurology

conversion reaction

coronary artery bypass

coronary thrombolysis

coronavirus

cortical infarction

cortical infarction, small

cortical vein thrombosis

cost

cost effectiveness

coumarin

coumarin, stopping treatment

COVID-19

craniectomy, decompressive

craniotomy

C-reactive protein

C-reactive protein, elevated

dementia, treatment of

denial of blindness(Antons syndrome)

denial of illness

dense basilar artery sign

dense middle cerebral artery sign

dense posterior cerebral artery sign

diagnosis related group

diagnostic criteria

diplopia

dipyridamole

disability rating scale, neurological

disability, neurological

dizziness

door to needle time

door to treatment time

doppler

doppler, transcranial

downward deviation of eyes

drip and ship

drop attacks

drug abuse

drug abuse, neurologic complications of

drug induced neurologic disorders

duplex ultrasound

dural sinus thrombosis

embolism, paradoxical

embolism, vertebral-basilar artery

emergencies, medical

emergencies, neurologic

emergencies, ocular

emergency medical technicians

emergency physician

emergency room

emergency room, treatment of stroke

endarterectomy, carotid

endarterectomy, carotid-complications of

endarterectomy, carotid-indications for

endarterectomy, carotid-timing after stroke

endocarditis

endocarditis, acute bacterial

endocarditis, infectious

endocarditis, neurologic manifestations with

endocarditis, subacute bacterial

endovascular therapy

endovascular therapy, late time window

endovascular therapy, time window

epidemiology of neurology

evidence-based research

failed medical management

falling

familial

fibrinogen depleting agents

fibrinolytic agents

fibrinolytic agents, repeated use

fibrinolytic agents, combined IA and IV

fibrinolytic agents, complications

fibrinolytic agents, contraindications

fibrinolytic agents, deterioration following

fibrinolytic agents, discontinuation

fibrinolytic agents, exclusion criteria

fibrinolytic agents, intra-arterial local infusion

fibrinolytic agents, intra-venous local infusion

fibrinolytic agents, utilization

fibrinolytic therapy, intraventricular

fibrinolytic therapy, prehospital treatment

fibrinolytic therapy, selection criteria

fibrinolytic therapy, timing of administration

fibroblast growth factor

fresh frozen plasma

gadolinium

gait disorder

gammaglobulin therapy, intravenous

gastrointestinal bleeding

glioblastoma multiforme(astrocytoma Gr.III)

glomerular filtration rate

glucose level, serum

Guillain Barre syndrome

hematoma, intracerebral

hematomyelia

hemianopia

hemianopia, homonymous

hemoglobin abnormality, neurologic complications of

hemopericardium

hemorrhagic diathesis

hemosiderosis of CNS, superficial

hemostatic therapy

heparin

heralding manifestation

hereditary hemorrhagic telangiectasia(HHT)

herniation syndromes, intracranial

hip abductor sign

hippocampal infarction

hirudin

Hispanics

Hoover's sign

hospital length of stay

hyperintense vessel sign

hyperperfusion syndrome

hypertension

hypotension, systemic

hypothermia

hypoxia

iatrogenic neurologic disorders

institutional review board

insular cortex

internal carotid artery

internal cerebral vein

internet

interobserver agreement

intracerebral hemorrhage

intracerebral hemorrhage, causes of

intracerebral hemorrhage, clot evacuation

intracerebral hemorrhage, incidence of

intracerebral hemorrhage, lobar

intracerebral hemorrhage, location of

intracerebral hemorrhage, multiple

intracerebral hemorrhage, pathophysiology

intracerebral hemorrhage, progression of

intracerebral hemorrhage, recurrent

intracerebral hemorrhage, small

intracerebral hemorrhage, treatment of

intracerebral hemorrhage, volume

intracranial hemorrhage

intracranial pressure, increased

intraventricular hemorrhage

intraventricular hemorrhage, clot evacuation

intraventricular hemorrhage, primary

intraventricular hemorrhage, treatment

lactic dehydrogenase(LDH)

lacunar infarction

lacunar infarction, differential diagnosis of

lawsuit

lecanemab

left handedness

left-right orientation

leg weakness, unilateral

leuko-araiosis

leukocytosis

level of consciousness

level of consciousness, decreased

level of consciousness, fluctuating

lumbar puncture, complications of

machine learning

malformation, vascular

malformation, vascular, cerebral

malformation, vascular, treatment of

medical-legal aspects of neurology

medication error

medullary streaks

medullary veins

memory, defect of recent

memory, impairment of

menses

mental status, abnormal

MERCI trial

microemboli

microhemorrhage, intracerebral

middle cerebral artery

middle cerebral artery territory infarction

middle cerebral artery territory infarction, malignant

middle cerebral artery, emboli to

middle cerebral artery, occlusion of

middle cerebral artery, stenosis of

migraine

mimics

misdiagnosis

mobile interventional stroke teams

monoclonal antibodies

MRI, angiography, contrast enhanced

MRI, CAT scan compared to

MRI, cerebrovascular disease

MRI, contrast enhanced

MRI, diffusion weighted

MRI, diffusion weighted, negative

MRI, diffusion weighted, reversal

MRI, disappearing lesion on

MRI, early changes in CVA

MRI, FLAIR, hyperintense vessels

MRI, flow void, blood

MRI, gradient-echo

MRI, gyral swelling

MRI, mismatch between DWI/FLAIR

MRI, mismatch between perfusion/diffusion

MRI, susceptibility weighted

MRI, venography

MRI, volumetry

MRS

multimodal neuroimaging

multiple sclerosis

myocardial infarction

myocardial infarction, acute

myocardial injury

negative

neoplasm, intracranial-incidence and epidemiology of

neoplasm, metastatic to CNS

neoplasm, metastatic to CNS, hemorrhagic

neoplasm, metastatic to CNS-hemorrhage into

neoplasm, primary intracerebral

neoplasm, primary of CNS

neoplasm, primary of CNS-hemorrhage in

neuritis, causes of

neurohospitalist

neurologic complications of, surgery

neurologic complications of, systemic disease

neurologic consultation

neurologic disease, diagnoses of

neurologic education

neurologic examination

neurologic examination, fluctuating

neurologic examination, focal

neurological intensive care

neurologist

neurology residency

neuropathy

neuroprotective agents

neuroradiology, interventional

NIH scale, fluctuating

NIH stroke scale

NIH stroke scale, fluctuating

NMDA antagonists

non-vitamin K antagonist oral anticoagulants

number needed to treat

nursing home

nystagmus

obesity

occipital lobe, infarction

old age, neurology of

optic neuropathy

oral contraceptives

oral contraceptives, cerbrovascular disease and

oral contraceptives, neurologic complications with

otitis, neurologic complications with

partial thromboplastin time

partial thromboplastin time, prolonged

patent foramen ovale

patient information and support

patient selection

peripheral blood smear, abnormal

perseveration

physician-patient relationship

pitfalls

placebo

platelet count

platelet inhibiting drugs

platelet inhibiting drugs, combined

platelet transfusion

point of care

posterior cerebral artery

posterior cerebral artery embolism

posterior cerebral artery occlusion

posterior cerebral artery territory infarction

posterior cerebral artery, fetal type

posterior fossa, lesion of

postoperative neurologic complications

postpartum

practice guidelines

pregnancy, neurologic complications in

prethrombotic state

prevention of neurologic disorders

radial pulse, unilateral decrease of

Rankin score

RAPID CT perfusion maps

readmissions

recanalization, arterial

recanalization, venous

recombinant activated factor VII

recurrent

regional cerebral blood flow

rehabilitation for neurologic disorders

reocclusion, cerebral artery

revascularization, surgical

reversible ischemia

review article

Reye's syndrome, prognosis of

risk factors

risk stratification

risk-benefit assessment

seizure, surgical treatment of

sensory loss

sickle cell crisis

sickle cell disease

single photon emission computed tomography

spinal cord, infarction of

spinal cord, ischemic lesion of

stent, basilar artery

stent, basilar artery, efficacy

stent, carotid artery

stent, vertebral artery

stereotaxic surgery

steroid

steroid therapy, CNS treatment and complications with

stool, guaiac positive

streptokinase

stroke center

stroke disability scale

stroke protocol

stroke protocol, activation

stroke team

stroke unit

stroke unit, mobile

stroke, progression of

strokelike episodes

strokologist

subarachnoid hemorrhage

subarachnoid hemorrhage, treatment of

subclavian vein catheterization

subdural hematoma

superior sagittal sinus thrombosis

thalamus, infarction of

thalamus, infarction, bilateral

thalamus, lesion of

thalamus, lesion of-bilateral

thrombectomy

thrombectomy, distal occlusion

thrombin inhibitor

thrombocytopenia

thrombolysis in cerebral infarction scale

thrombolysis, mechanical

thrombus, intracardiac

tissue plasminogen activator antigen

tissue plasminogen activator, intravenous

Todd's paralysis

tongue, hematoma

tongue, swelling

top of the basilar syndrome

transient ischemic attack

transient ischemic attack, treatment of

transluminal angioplasty, basilar artery

transluminal angioplasty, carotid artery

transluminal angioplasty, intracranial

transluminal angioplasty, intracranial-indications for

transluminal angioplasty, middle cerebral artery

transluminal angioplasty, vertebral artery

transport of patient

treatment delay

treatment of neurologic disorder

trial design

ultrasonography

ultrasonography, carotid artery

ultrasonography, head

uncal herniation

unconsciousness

unconsciousness, transient

vertebral artery occlusion

vertebral artery stenosis

vertebral-basilar artery, atherosclerosis

vertebral-basilar artery, intraluminal clot

vertebral-basilar insufficiency

vertigo

vestibular function, tests of

visual acuity, decreased

visual acuity, decreased, monocular

visual loss, sudden-unilateral

Showing articles 100 to 150 of 668 << Previous Next >>

Immediate Hemorrhagic Transformation After Intravenous Tissue-Type Plasminogen Activator Injection in 2 Cocaine Users
Stroke 46:e167-e169, Baud, M.O.,et al, 2015

Hyperintense Vessels on FLAIR: Hemodynamic Correlates and Response to Thrombolysis
AJNR 36:1426-1430, Kufner, A.,et al, 2015

Microbleed Status and 3-Month Outcome After Intravenous Thrombolysis in 717 Patients with Acute Ischemic Stroke
Stroke 46:2458-2463,2403, Turc, G.,et al, 2015

Treatment Concepts for Wake-Up Stroke and Stroke with Unknown Time of Symptom Onset
Stroke 46:2707-2713, Thomalla, G. & Gerloff, C., 2015

Cost-Utility Analysis of Mechanical Thrombectomy Using Stent Retrievers in Acute Ischemic Stroke
Stroke 46:2591-2598, Ganesalingam, J.,et al, 2015

Basilar Occlusion Syndromes: An Update
Neurohosp 5:142-150, Demel, S.L. & Broderick, J.P., 2015

Intravenous Fibrinolytic Therapy in Central Retinal Artery Occlusion
JAMA Neurol 72:1148-1154, Schrag, M.,et al, 2015

IV Thrombolysis in Patients with Ischemic Stroke and Alcohol Abuse
Neurol 85:1592-1597, Gattringer, T.,et al, 2015

IV Thrombolysis in very severe and severe ischemic stroke
Neurol 85:2098-2106, Mazyam, M.V.,et al, 2015

Endovascular Therapy is Effective and Safe for Patients with Severe Ischemic Stroke
Stroke 46:3416-3422, Broderick, J.P.,et al, 2015

Endovascular vs Medical Management of Acute Ischemic Stroke
Neurol 85:1980-1990, Chen, C.J.,et al, 2015

Hemi Orolingual Angioedema after tPA Administration for Acute Ischemic Stroke
West J Emerg Med 16:175-177, Madden, B. & Chebl, R.B., 2015

Brush Sign on 3-T T2* - Weighted MRI as a Potential Predictor of Hemorrhagic Transformation After Tissue Plasminogen Activator Therapy
Stroke 45:274-276, Terasawa, Y.,et al, 2014

4.5-Hour Time Window for Intravenous Thrombolysis with Recombinant Tissue-Type Plasminogen Activator is Established Firmly
Stroke 45:912-913,916, Schellinger, P.D. & Kohrmann, M., 2014

The 4.5-HourTime Window for Intravenous Thrombolysis with Intravenous Tissue-Type Plasminogen Activator is Not Firmly Established
Stroke 45:915-915,916, Wechsler, L.R., 2014

Preexisting Cerebral Microbleeds on Susceptibility-Weighted Magnetic Resonance Imaging and Post-Thrombolysis Bleeding Risk in 392 Patients
Stroke 45:1684-1688, Gratz, P.P.,et al, 2014

Remote or Extraischemic Intracerebral Hemorrhage - An Uncommon Complication of Stroke Thrombolysis
Stroke 45:1657-1663, Mazya, M.V.,et al, 2014

Reperfusion Therapies for Wake-Up Stroke
Stroke 45:1869-1875, Buck, D.,et al, 2014

Safety of Thrombolysis in Patients with Acute Ischemic Stroke and Cerebral Cavernous Malformations
Stroke 45:1846-1848, Erdur, H.,et al, 2014

Unexplained Early Neurological Deterioration After Intravenous Thrombolysis
Stroke 45:2004-2009, Seners, P.,et al, 2014

Symptomatic Intracerebral Hemorrhage in Acute Ischemic Stroke After Thrombolysis With Intravenous Recombinant Tissue Plasminogen Activator
JAMA Neurol 81:1181-1185, Yaghi, S.,et al, 2014

Number of Cerebral Microbleeds and Risk of Intracerebral Hemorrhage after Intravenous Thrombolysis
Stroke 45:2900-2905, Dannenberg, S.,et al, 2014

Stroke and the Law
Stroke 45:3141-3146, Fisher, M. & Schneider, P., 2014

New Microbleeds after Thrombolysis
Medicine 93:e99, Yan, S.,et al, 2014

Is Intra-Arterial Thrombolysis Beneficial for M2 Occlusions? Subgroup Analysis of the PROACT-II Trial
Stroke 44:240-242, Rahme, R.,et al, 2013

Prehospital Thrombolysis in Acute Stroke
Neurol 80:163-168, Weber, J.,et al, 2013

An Observational Study of Thrombolysis Outcomes in Wake-Up Ischemic Stroke Patients
Stroke 44:427-431, Manawadu, D.,et al, 2013

Safety of Thrombolysis in Stroke Mimics
Stroke 44:1080-1084, Zinkstok, S.M.,et al, 2013

Endovascular Treatment for Acute Ischemic Stroke-Still Unproven
NEJM 368:952-955, Chimowitz,M., 2013

Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke
NEJM 368:893-903,952, Broderick, J.P.,et al, 2013

Endovascular Treatment for Acute Ischemic Stroke
NEJM 368:914-923,952, Ciccone, A.,et al, 2013

Treatment of Patients with Suspected Ischemic Stroke of Undetermined Onset and Negative Head Computed Tomography Scan
Stroke 44:1494-1495, Adams, H., 2013

A Plain Computed Tomography Scan is Sufficient to Consider Thrombolysis in Patients with Unknown Time of Onset
Stroke 44:1492-1493, Alexandrov, A., 2013

Computed Tomography Angiography in Hyperacute Ischemic Stroke
Stroke 44:1480-1488, Mortimer, A.,et al, 2013

Negative Diffusion-Weighted Imaging After Intravenous Tissue-Type Plasminogen Activator is Rare and Unlikely to Indicate Averted Infarction
Stroke 44-1629-1634, Freeman, J.,et al, 2013

Thrombolysis Despite Recent Stroke
Stroke 44:1736-1738, Alhazzaa, M.,et al, 2013

Results of Intravenous Thrombolysis within 4.5 to 6 Hours and Updated Results within 3 to 4.5 Hours of Onset of Acute Ischemic Stroke Recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR)
JAMA Neurol 70:837-844, Ahmed, N.,et al, 2013

Comparison of Final Infarct Volumes in Patients who Received Endovascular Therapy or Intravenous Thrombolysis for Acute Intracranial Large-Vessel Occlusions
JAMA Neurol 70:831-836, Rangaraju, S.,et al, 2013

A Case-Controlled Comparison of Thrombolysis Outcomes Between Wake-Up and Known Time of Onset Ischemic Stroke Patients
Stroke 44:2226-2231, Manawadu, D.,et al, 2013

Thrombolysis of Basilar Artery Occlusion: Impact of Baseline Ischemia and Time
Ann Neurol 73:688-694, Strbian, D.,et al, 2013

New Appearance of Extraischemic Microbleeds on T2*-Weighted Magnetic Resonance Imaging 24 Hours After Tissue-Type Plasminogen Activator Administration
Stroke 44:2776-2781, Kimura, K.,et al, 2013

Thrombolysis for Ischemic Stroke Associated with Infective Endocarditis
Stroke 44:2917-2919, Asaithambi, G.,et al, 2013

Safety of Intravenous Thrombolysis for Ischemic Stroke in Patients Treated with Warfarin
Ann Neurol 74:266-274, Mazya, M.V.,et al, 2013

Serum Creatinine May Indicate Risk of Symptomatic Intracranial Hemorrhage after Intravenous Tissue Plasminogen Activator (IV tPA)
Medicine 92:317-323, Marsh, E.B.,et al, 2013

IV Thrombolysis and Renal Function
Neurol 81:1780-1788, Gensicke, H.,et al, 2013

Thrombolysis for Acute Ischemic Stroke in Patients with Cancer
Stroke 44:3573-3576, Murthy, S.B.,et al, 2013

Glycosylated Hemoglobin A1 Predicts Risk for Symptomatic Hemorrhage After Thrombolysis for Acute Stroke
Stroke 44:2134-2138, Rocco, A.,et al, 2013

What is Meant by "TICI"?
AJNR 34:1792-1797, Fugate,J.E.,et al, 2013

The Safety of Intravenous Thrombolysis for Ischemic Stroke in Patients with Pre-Existing Cerebral Aneurysms
Stroke 43:412-416, Edwards,N.J.,et al, 2012

The Argatroban and Tissue-Type Plasminogen Activator Stroke Study
Stroke 43:770-775,623, Barreto,A.D.,et al, 2012

Showing articles 100 to 150 of 668 << Previous Next >>